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ABSTRACT 
To maintain viability, cells must resolve misfolded protein stress; the inability to 
do so often triggers cell death, most notably in neurons during neurodegenerative disease. 
The NAC is a highly conserved translational chaperone essential for protein folding and 
localization to organelles throughout the cell. In C. elegans, depletion of the NAC 
initiates misfolded protein stress specifically in the endoplasmic reticulum, inducing a 
response that upregulates the HSP-4 chaperone in an attempt to prevent cell death. This 
upregulation is robust but not uniform, and deficient in regions containing neurons. We 
are characterizing this non-uniform stress response to determine if HSP-4 upregulation is 
cell-specific and correlates with survival.  Additionally, there is evidence that the NAC 
may function in engaging premature and/or atypical differentiation under stress 
conditions. We’ve developed a protocol that characterizes the differentiation patterns and 
stress responses in NAC-depleted C. elegans. Our results indicate that NAC-depleted C. 
elegans have altered gut cell differentiation patterns when compared to control 
treatments. Furthermore, control studies were conducted to determine baseline patterns of 
HSP-4 expression in relation to the location of gut cells. Future studies will investigate 
differentiation patterns of muscle and neuronal cells in NAC-depleted C. elegans as well 
as characterizing the upregulation of HSP-4 in gut, muscle, and neuronal cells within 
NAC-depleted C. elegans.   
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INTRODUCTION 
Proteins are versatile macromolecules essential for the function of every cell in 
the body. The structure of a protein determines its function and is itself defined by the 
content and order of the amino acids that make up the protein. Amino acids form proteins 
through dehydration synthesis reactions in which a peptide bond is formed between two 
adjacent amino acids. The linking of amino acids forms a chain of peptide bonds that 
leads to the formation of the primary structure of a polypeptide. As the chain emerges 
from the ribosomal complex during translation, adjacent amino acids interact via 
hydrogen bonding to form twists and folds that result in secondary structures, e.g. alpha 
helical structures and beta-pleated sheets. Subsequently, secondary structures interact 
with each other depending on the nature of their specific amino acid R-groups, which 
form ionic bonds, disulfide bridges and hydrophobic interactions and generate the tertiary 
structure of the polypeptide. Many amino acid chains become immediately functional 
once they have folded into their proper structure, while some interact with other amino 
acid chains, forming quaternary structure required for functionality1 
Proper protein folding during translation followed by maintenance of that folded 
structure are essential for protein function and therefore cell viability. The flow of 
information required to generate a functional protein initiates from the nucleus and 
terminates in the cytoplasm: a gene is transcribed into a primary mRNA that is processed 
to make a mature mRNA. These mRNAs are read by ribosomal complexes, generating a 
chain of amino acids that interact to create the initial structure of the polypeptide. The 
early stages of protein folding are the foundation for the final protein structure and if not 
properly conducted, will result in a misfolded protein that is either nonfunctional or 
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differentially functioned. Misfolded proteins often result from exogenous stress on the 
cell, and can accumulate in different cellular compartments. Misfolded proteins can cause 
damage by forming aggregates that interact with cellular organelles and/or perpetuating 
the misfolding of other proteins2. Specifically, the endoplasmic reticulum (ER) is 
susceptible to aggregation of misfolded protein during periods of stress generated by 
heat, toxins, aging, and nutrient deficiencies; stress events that generate misfolded protein 
in the ER can lead to the death of the cell if the stress is chronic or acute3 
Under normal conditions, the ER is responsible for the first step in proper protein 
folding. The rough ER is responsible for synthesizing nascent polypeptides that will 
become functional proteins whereas the smooth ER is responsible for maintaining and 
processing these polypeptides4. Under stress conditions, the accumulation of misfolding 
peptide chains can overwhelm the folding mechanisms of the ER, resulting in 
accumulation and aggregation within the lumen4. To prevent this occurrence, the stressed 
cell engages the ER-specific unfolded protein response (UPR), which initiates cell-saving 
mechanisms to help alleviate the misfolded protein accumulation and aid the cell in 
coping with cell stress5. When the misfolded protein stress is too acute or chronic to 
allow for timely resolution, the UPR will initiate mechanisms that kill the cell, primarily 
via apoptosis; the UPR-mediated outcome is what putatively links ER misfolded protein 
stress to a number of human diseases. By way of an example, most, if not all, 
neurodegenerative disease pathologies include the accumulation of misfolded proteins6. 
There are multiple hypotheses regarding the origin of the protein accumulation in 
neurodegenerative diseases and its contribution to disease progression, including 
disrupted function of the ER due to high levels of misfolded proteins not processed 
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efficiently before aggregating2,4. Ultimately, the accumulation of misfolded proteins is 
thought to trigger cell death as a mechanism to protect the organism; this cell death is 
what likely links misfolded protein stress and the subsequent induction of the UPR to the 
apoptotic loss of neurons observed during neurodegeneration7.  
To establish and maintain properly folded proteins and avoid the damage 
associated with misfolded protein stress, the cell expresses chaperones, a family of 
proteins dedicated solely to aiding in protein folding. Chaperones are expressed 
throughout the cell’s life and constitute the proteostasis network that regulates both 
nascent protein folding and the refolding of misfolded proteins8. Chaperones work 
individually and in combination to control the folding environment of polypeptides; they 
prevent nascent chain misfolding during translation, and refold misfolded proteins to their 
native states during stress. When misfolded protein stress becomes acute and/or chronic, 
chaperones are also known to shuttle misfolded proteins to degradation pathways9,10. 
Individual chaperone functions have been characterized11 as well as the inter-related 
interactions that constitute the chaperome, a complex network of cooperative chaperone 
relationships that regulate the structures of both nascent proteins and misfolded proteins8. 
Within the chaperone family are heat shock proteins (HSPs), a class of 
chaperones originally associated with heat stress that bind polypeptides and assist with 
folding. Heat shock proteins are ubiquitous and abundant, comprising approximately 1-2 
percent of the total proteins within a cell12. Their primary role is to prevent any 
misfolding events and aggregation during cell stress13. There are multiple classes of heat 
shock proteins, classified by the molecular weight of the founding member, all with 
specific functions: small HSPs, HSP40, HSP70, HSP90, and HSP100. Small HSPs 
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prevent the initial accumulation of aggregated proteins. If aggregates occur, HSP40 
chaperones deliver the aggregated proteins to HSP70 chaperones, which associate with 
HSP100 chaperones to dissolve and reactivate misfolded proteins in an ATP-dependent 
manner. Once these aggregates have been properly refolded, HSP90 chaperones maintain 
this folded state12,14. Of these classes, HSP70 members have been extensively studied and 
highly conserved throughout evolution, with a subset, including BiP, specific to the 
management of misfolded protein in the ER13.  
In addition to the HSPs, there are other classes of chaperones less well 
characterized, but still essential for proper protein folding, including those that bind to 
nascent polypeptides as they emerge from the ribosome, otherwise known as translational 
chaperones.  The nascent polypeptide associated complex (NAC) is a translational 
chaperone complex that exists as a heterodimer with two subunits, alpha and beta; the 
beta subunit is responsible for the NAC’s association with the ribosomal complex15. 
Specifically, the NAC is responsible for promoting nascent protein folding as well as 
protein localization during translation, and therefore is directly maintains proteostasis and 
cell viability16,17. Therefore, the NAC plays an essential role in the control of protein 
folding and localization to different organelles and the complete loss of the NAC causes 
lethal phenotypes in many organisms, including mice and Drosophila melanogaster.  
While the initial characterizations of the NAC were performed primarily in yeast, 
recently important insights into the functions of this complex have been gained in 
metazoans, including Caenorhabditis elegans (C. elegans). As with mice and Drosophila, 
a complete genetic knockout of either subunit of the NAC in C. elegans is embryonically 
lethal18. As such, knockdown experimental procedures of the NAC, e.g. through the use 
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of RNA interference, is necessary for investigating the roles of this complex in protein 
folding. Through depletion of one or the other subunit, it has been determined the 
depletion of the NAC in C. elegans results in accumulation of misfolded protein stress in 
the ER, presumably due to the mislocalization of poorly folded proteins to the ER in the 
absence of NAC’s translational chaperone function16. This accumulation results in the 
induction of the UPR, which initiates both cell-saving and cell-killing responses 
depending on the severity and duration of the stress19.  
The UPR has three key proteins that are variably engaged during a stress 
response: IRE-1, ATF6, and PERK/PEK-1. The initial actions of the UPR engage several 
cell-saving mechanisms, including an attenuation of translation, increased chaperone 
expression, increased protein degradation and turnover, and expansion of the lumenal 
area of the ER5. When these cell saving responses are unable to resolve the stress in a 
timely fashion, the UPR engages cell killing mechanisms to remove the damaged cell 
from the organism. These cell deaths are primarily via apoptosis, although UPR-mediated 
autophagy has also been shown to contribute in certain contexts (Figure 1). While the 
UPR has been previously characterized in the context of stress response, there is 
gathering evidence that the UPR is also engaged to drive the differentiation of certain cell 
types5,20.  
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Figure 1. The Unfolded Protein Response (UPR) mechanism engaged in the presence of misfolded protein 
stress. The three key proteins of the UPR are IRE-1, ATF6, and PERK/PEK-1. The UPR engages several 
mechanisms, including translation attenuation, increased chaperone expression, increased protein 
degradation and turnover, and ER biogenesis during times of misfolded protein stress. The UPR engages 
cell killing mechanisms when the cell-saving mechanisms are unable to resolve the stress. These cell deaths 
are via apoptosis and autophagy. Figure adaptation21.  
 
While the NAC is a heterodimer that functions as a translational chaperone, there 
is strong evidence that the subunits also function independently of each other. For alpha 
NAC, there is compelling evidence for a role as a transcription factor in the regulation of 
cell differentiation, consistent with alpha NACs ability to translocate from the cytoplasm 
to the nucleus when not bound by beta NAC22. Specifically, alpha NAC helps regulate 
osteoblast development in mice22,23. In this role, alpha NAC interacts with histone 
deacetylases to both upregulate and downregulate a suite of osteocalcin genes that 
promotes osteoblast maturation and bone mineralization during development24,25. In 
addition to its role in bone cell differentiation, alpha NAC acts as a positive regulator of 
erythroid cell differentiation although there are no specific mechanisms to elucidate this 
	  13	  
pathway currently26. Initially identified and characterized in the context of its role in the 
NAC complex, alpha NAC itself appears to have a multitude of functions above and 
beyond the protein folding regulation and localization that it performs when bound to 
beta NAC.  
Alpha NAC has been relatively well characterized in terms of its independent 
roles; less is known about the role(s) of beta NAC when not bound by alpha NAC. In the 
absence of alpha NAC, beta NAC has the ability to stop ribosome binding to the ER, 
likely a reflection of its role to control protein localization during translation. Beyond this 
analysis, characterization of beta NAC has been performed in the context of depletion of 
the subunit15. Initial studies of beta NAC in C. elegans identified it as a repressor of 
apoptosis. Specifically, a decrease in beta NAC levels increases apoptosis early in 
embryogenesis, with neurons being particularly susceptible18. Similarly, in human cell 
lines, the down-regulation of beta NAC has been correlated with apoptosis27,28. Recent 
evidence links beta NAC’s ability to suppress apoptosis and prevention of misfolded 
protein stress to the activation of the UPR and subsequent induction of apoptosis16. The 
evidence of beta NAC as an inhibitor of apoptosis is based solely on phenotypes 
generated in its absence, making it impossible to determine if these results are due to the 
loss specifically of beta NAC, the loss of the NAC, or both. In support of beta NAC 
having an anti-apoptotic function above and beyond its role in the NAC, overexpression 
of beta NAC in the presence of normal expression levels of alpha NAC leads to the 
survival of cells that are normally eliminated by apoptosis during embryonic 
development29. 
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There is ample evidence that the NAC and its individual subunits play important 
roles in the management of misfolded protein stress in the ER, as well as potential roles 
in the control of certain cell differentiation programs. There is also evidence that stress 
induced by the depletion of the NAC is tolerated differentially by different cell types, 
with neurons being particularly susceptible to apoptotic cell death. Our research has 
focused on the link between the depletion of the NAC and cell-specific responses, 
including the putative role(s) of the individual subunit when in excess to its binding 
partner. To determine the role of the NAC in cell specific responses to misfolded protein 
stress, C. elegans embryos with fluorescently tagged cell lineages, specifically intestinal 
cells, were manipulated. In order to characterize both the stress response and the timing 
of cell differentiation in these embryos, alpha NAC, beta NAC or both were depleted.  
Our hypothesis was that the depletion of either NAC subunit will induce UPR cell-saving 
responses in gut cells, while a relative abundance of alpha NAC during the depletion of 
beta NAC will drive gut cells to differentiate earlier relative to gut cells in wild-type 
organisms.  
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METHODS 
Care and Maintenance of C. elegans  
C. elegans wild-type and mutant worms with GFP and/or RFP reporter constructs were 
maintained on Nematode Growth Medium (NGM) (Carolina Biological) plates that 
contained the Escherichia coli strain, OP50-1, as a food source. Worms were maintained 
at 22 °C. Short term maintenance involved the transfer of adults to freshly seeded OP50-
1/ NGM plates every 3-4 days. 
  
hsp-4::GFP and Cell Lineage Reporter Strains  
Heat Shock Protein 4::Green Fluorescent Protein (hsp-4::GFP), the C. elegans homolog 
of Heat Shock Protein 70, and Gut::Red Fluorescent Protein (Gut::RFP) strains were 
acquired from the Caenorhabditis Genetics Center (CGC) at the University of Minnesota. 
The HSP-4 construct consists of the gene expression control region of the specified hsp-4 
fused to GFP. The Gut::RFP strain contains a fluorescently tagged Pvha6::mRFPPTS1 
attached to the unc119 gene, localizing RFP signal to peroxisomes in intestinal cells. 
  
Bacterial Culture Maintenance 
Bacterial cultures of E. coli OP50-1 and strains with RNAi plasmids were prepared 
weekly using Luria Broth culture media. Cultures were prepared with 10mL of Luria 
Broth and a pure culture inoculate of the respective E. coli strain. Antibiotics were added 
to the cultures to prevent unwanted growth of other microorganisms; 50 ug /mL 
ampicillin for RNAi plasmid strains and 50 ug /mL streptomycin for OP50-1. Cultures 
were incubated with shaking at 37 °C for 12 hours. After 12 hours, cultures were 
transferred to sterile 15mL tubes and refrigerated at 3.6 °C. 
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Mounting C. elegans for microscopy 
Slides were prepared by placing a small amount, approximately 100uL, of liquefied 
bacteriological agar onto a slide and pressing an additional slide to allow the liquefied 
agar to spread. The slides were allowed to sit for approximately two minutes before 
removing the top slide to expose the thin layer of agar. Approximately 30uL of M9 salt 
solution (22mM KH2PO4, 11mM Na2HPO47H2O, 85mM NaCl, 1mM MgSO4) was 
placed onto the center of the thin agar layer to allow for embryo transfer. Approximately 
30uL of 3mM levamisole solution, suspended in M9, was placed onto the center of the 
thin agar layer to allow for adult transfer. Organisms were transferred from plates, either 
NGM agar seeded with E.coli OP50-1 or RNAi plates seeded with E.coli containing 
respective plasmids for dsRNA, to slides. The excess bacteria on the slide were removed 
from the M9 salt solution using a toothpick with an attached eyelash to move the bacteria 
out of the solution. This was done to clear the agar layer of bacteria in order to maintain a 
clear visual field for microscopy. Once the bacteria were removed from the solution, a 
coverslip was added to the slide. The sides of the coverslip were sealed to prevent the 
slide from drying out during observation. 
  
RNA Interference Plates and Cultures 
To reduce ICD-1 and ICD-2 protein levels, RNA interference (RNAi) assay was 
employed. RNAi assay utilizes double-stranded (ds) RNA specific to the mRNA of a 
targeted gene to reduce the levels of the corresponding protein. The gene products of icd-
1 and icd-2 were targeted by RNAi assays to determine the effects of reductions of ICD-1 
and ICD-2 proteins on the expression of gut cells and the HSP-4 protein. Feeder bacteria 
expressing the appropriate dsRNA were obtained from Addgene, and grown from single 
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colonies in liquid LB by shaking overnight at 37oC.The dsRNA specific to icd-1 and icd-
2 genes were introduced into larval worms, specifically L4 larvae, using a feeding 
method in which NGM plates were seeded with a culture of E. coli OP50-1 constructed 
with a plasmid with dsRNA that targeted one or the other subunit. RNAi plates were 
made by combining 4.5g NaCl, 25.5g agar, 3.75g peptone, 1.5mL of 2mg/mL uracil, 
0.22g CaCl 0.75g of 10mg/ml cholesterol in 1463mL of dH2O. This mixture was 
autoclaved, allowed to cool, and 37.5mL of phosphate buffer (pH 6), 1.5mL of 1M 
MgSO4, 15uL of 0.1M IPTG (for induction of the dsRNA expression) and 1.5mL of 
25mg/mL ampicillin (for selection of the dsRNA-expressing plasmid) were added. 
   
Male Generation 
Male C. elegans are typically produced through a chromosomal nondisjunction event 
during meiosis to produce an XO organism. To encourage a nondisjunction event, heat 
shock was employed. L4 larvae and early adult worms were moved to an NGM plate and 
incubated in 30°C for 6 hours. After 6 hours, the plate was removed and returned to 22 
°C and organisms were allowed to recover. After organisms recovered, progeny were 
observed with a dissection microscope to screen for males. Their characteristic arrow 
shaped tail and overall smaller appearance in comparison to hermaphroditic worms 
physically identified male C. elegans. 
 
Worm Strain Generation Through Genetic Crosses  
Male worms were developed in the gut cell lineage reporter strain through heat shock. 
These males were crossed with hermaphrodites from the hsp-4::GFP strain and the F1  
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hermaphroditic progeny were and isolated on separate plates. Resulting F2 progeny were 
singled onto individual plates and their progeny were characterized for Gut::RFP and 
hsp-4::GFP presence. F2 worms producing 100% progeny showing both Gut::RFP and 
hsp-4::GFP were considered to be homozygous for the fluorescent alleles of both genes. 
 
RNAi Assay for Embryo Characterization 
Twenty to thirty L4 larvae were moved to a seeded RNAi (icd-1(RNAi), icd-2(RNAi), or 
icd-1/icd-2(RNAi)) plate, designated plate 1. After 12 hours, the original L4 worms were 
moved to plate 2. After worms were moved, the embryos on plate 1 were moved to a 
slide and analyzed. After 24 hours, the original L4 worms were moved to plate 3. After 
worms were moved, the embryos on plate 2 were moved to a slide and analyzed with 
confocal microscopy. After 36 hours, the original L4 worms were moved to plate 4. After 
worms were moved, the embryos on plate 3 were moved to a slide and analyzed. After 48 
hours, the original L4 worms were taken off plate 4 and sacrificed. After worms were 
sacrificed, the embryos on plate 4 were moved to a slide and analyzed. To conduct a 
control treatment in which no RNAi was implemented, embryos were moved directly 
from an E. coli OP50-1 seeded NGM plate. All observation and analysis was conducted 
using confocal microscopy (Figure 2a).  
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Figure 2a. RNAi assay protocol diagram for Gut Characterization.  
 
RNAi Assay for Colocalization of Heat Shock Protein 4 and Gut Cell 
Twenty to thirty L4 larvae were moved to a seeded RNAi (icd-1(RNAi), icd-2(RNAi), or 
icd-1/icd-2(RNAi)) plate, designated plate 1. After 12 hours, the original L4 worms were 
moved to plate 2. After worms were moved, the embryos on plate 1 were allowed to 
develop for 48 hours. The developed adults were moved to slide and analyzed. After 24 
hours, the original L4 worms were moved to plate 3. After worms were moved, the 
embryos on plate 2 were allowed to develop for 48 hours. The developed adults were 
moved to slide and analyzed. After 36 hours, the original L4 worms were moved to plate 
4. After worms were moved, the embryos on plate 3 were allowed to develop for 48 
hours. The developed adults were moved to slide and analyzed. After 48 hours, the 
original L4 worms were taken off plate 4 and sacrificed. After worms were sacrificed, the 
embryos on plate 4 were allowed to develop for 48 hours. The developed adults were 
moved to slide and analyzed. To conduct a control treatment in which no RNAi was 
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implemented, adult worms were moved directly from an E. coli OP50-1 seeded NGM 
plate. All observation and analysis was conducted using confocal microscopy (Figure 
2b). 
 
 
Figure 2b. RNAi assay protocol diagram for Colocalization of Heat Shock Protein 4 and Gut Cell.  
 
Confocal Microscopy for Gut Characterization Embryos 
Prepared slides were observed using the Nikon C1 Inverted Laser Scanning Confocal 
Microscope. The fluorescent channels used were DsOrange (561nm) to detect Gut::RFP 
signal. For DsOrange, the fluorescent channels were set to the following thresholds: the 
HV/gain was set to 155, the offset was set to 0, and the laser power was set to 1.44. Each 
embryo was observed to determine stage and presence of signal. Stages were determined 
according to physical characteristics. The first identifiable stage is 390 to 420 minutes 
after first cleavage (comma stage) and is characterized by an invagination from the 
embryo shell. The second stage is 460 to 520 minutes after cleavage (two-fold stage) and 
is characterized by a larger invagination causing an elongation of the two sides of the 
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embryo forming a U-shaped organism. The third stage is 520 minutes to 620 minutes 
after cleavage (three-fold stage) and is characterized by an S-shaped organism that has 
three distinct folds within the embryo shell. The final stage before hatching is 620 
minutes to 800 minutes after cleavage (four-fold stage) and is characterized by an 
elongated worm that is shaped like a four-fold. The number of embryos with or without 
signal was recorded for each stage. The total number of embryos (separated by stage) that 
displayed signal were recorded and divided by the total number of observed embryos. 
This value was recorded as a percentage of embryos with signal for each developmental 
stage. If there was signal present, a captured Differential Interference Contrast (DIC) 
image and fluorescent composite image was saved for further reference and analysis. Z 
stack fluorescent images were captured for each respective fluorescent channel for each 
embryo. 
 
Confocal Microscopy for Colocalization of Heat Shock Protein 4 and Gut Cell 
Prepared slides were observed using the Nikon C1 Inverted Laser Scanning Confocal 
Microscope. The fluorescent channels used were DsOrange (561nm) to detect Gut::RFP 
signal and GFP (488nm) to detect hsp-4::GFP signal. For DsOrange, the fluorescent 
channels were set to the following thresholds: the HV/gain was set to 155, the offset was 
set to 0, and the laser power was set to 1.44. For GFP, fluorescent channels were set to 
the following thresholds: the HV/gain was set to 133, the offset was set to 0, and the laser 
power was set to 1.44. A captured Differential Interference Contrast (DIC) image and 
fluorescent composite image was saved for further reference and analysis. Z stack 
	  22	  
fluorescent images were captured for each respective fluorescent channel for each adult 
worm.  
Digital Analysis with ImageJ for Gut Characterization Embryos 
Confocal images were uploaded into ImageJ  (National Institute of Health) utilizing the 
Bioformats plug-in to interpret the Nikon file format. Images were uploaded as a 
hyperstack in grayscale and subsequently analyzed. Utilizing the “Analyze Particle” 
function, the bounded region of the embryo, as identified from a captured DIC image, 
was analyzed to report the number of particles, the area of the region analyzed, and the 
mean intensity per stack in each hyperstack. These data were reported in a Microsoft 
Excel file and saved for further analysis.  
 
Digital Analysis with ImageJ for Colocalization of Heat Shock Protein 4 and Gut Cell 
Confocal files were uploaded into ImageJ (National Institute of Health) utilizing the 
Bioformats plug-in to interpret the Nikon files. Images were uploaded as a hyperstack in 
grayscale and subsequently analyzed. The channels of the DsOrange and GFP were split 
for colocalization analysis. The “Colocalization” plug-in was set to threshold values of 0. 
The composite image was then split into three channels: DsOrange, GFP, and 
Colocalized. The Colocalized channel was analyzed with the “Analyze Particle” function 
within the bounded region of the adult, as identified from a captured DIC image, to report 
the number of particles and the area of the region selected. These data were reported in a 
Microsoft Excel file and saved for further analysis. 
  
Statistical Analysis for Gut Characterization Embryos 
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The excel files containing data from the ImageJ (National Institute of Health) analysis 
were compiled into a single Microsoft Excel file and analyzed. The average pixels per 
area unit were determined by dividing the sum of pixel counts by the sum of total area 
analyzed for each individual stack within the embryo to determine the overall average 
pixels per area unit for the entire hyperstack. Additionally, the mean pixel intensity per 
stack was averaged to determine the overall mean pixel intensity for the entire 
hyperstack. Data from comma and two-fold embryos was not analyzed due to lack signal 
in all observed embryos. Each data set from the three-fold and four-fold stages were 
separated based on time point (12 hour, 24 hour, 36 hour or 48 hour). Once data was 
compiled, the 48 hour time point was disregarded due to lack of discernable embryos and 
lack of data points for analysis. After data was compiled by time point and by stage, the 
data were averaged and standard deviation was determined for each time point and stage 
for each RNAi treatment. A two-way ANOVA was conducted to compare different time 
points of each RNAi treatment separated by stage for mean pixels per area unit and mean 
pixel intensity. Additionally, a Tukey post-hoc test was conducted to determine any 
statistically significant difference between the time points for each treatment and stage. 
Another two-way ANOVA was conducted to compare different RNAi treatments at each 
time point separated by stage for mean pixels per area unit and mean pixel intensity. 
Additionally another Tukey post-hoc test was conducted to determine any statistically 
significant difference between the RNAi treatments for each time point and stage.  
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RESULTS 
Depletion of the ICD-1 and/or  ICD-2 subunit significantly affects percentage of embryos 
expressing RFP signal 
To characterize the effect of NAC individual subunit depletion on the presence of 
gut cells, ICD-1, ICD-2, and ICD-1/ICD-2 depleted embryos were examined for reporter 
signal. Signal from the Gut::Red Fluorescent Protein (RFP) strain worm, containing a 
fusion gene, localizes an RFP signal to peroxisomes in intestinal cells. Therefore the 
presence of RFP is indicative of gut cell differentiation. During observation, the presence 
of RFP was only seen beginning in the third stage (520 minutes to 620 minutes after 
cleavage, three-fold stage) and continuing into the fourth stage (620 minutes to 800 
minutes after cleavage, four-fold stage). The number of embryos with or without signal 
was recorded for each stage. The total number of embryos (separated by stage) that 
displayed RFP was recorded and divided by the total number of observed embryos. The 
number of embryos produced at the 48 hour time point was dramatically diminished, and 
those that were present were extremely disrupted morphologically as to be indiscernible 
due to the prolonged RNAi exposure. Therefore, the 48 hour time point was excluded 
from further data analysis.  
The percentages of three-fold embryos with RFP signal during icd-1(RNAi) 
treatment by time points (12 hours, 24 hours, and 36 hours)  were: 47.83%, 54.69%, and 
38.00%, respectively, while during icd-2(RNAi) treatment, they were: 32.61%, 25.97%, 
and 16.16%, respectively. The percentages of three-fold embryos with RFP signal during 
icd-1/icd-2(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) were: 
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55.56%, 20.51%, and 29.73%, respectively. The percentage of untreated three-fold 
embryos with RFP signal was 90.91% (Table 1).  
 
Table 1. Percentage of three-fold stage embryos with RFP signal in comparison to total 
number of embryos viewed during indicated RNAi treatment .  
Percentage of three-fold embryos with RFP signal  
  icd-1(RNAi) icd-2(RNAi) icd-1/icd-2(RNAi) Control 
12 hours 47.83 32.61 55.56 90.91 
24 hours 54.69 25.97 20.51 
 36 hours 38.00 16.16 29.73 
  
The percentages of four-fold embryos with RFP signal during icd-1(RNAi) 
treatment by time points (12 hours, 24 hours, and 36 hours) were: 60.00%, 38.89%, and 
52.94%, respectively while during icd-2(RNAi) treatment, they were: 44.44%, 66.67%, 
and 23.68%, respectively. The percentages of four-fold embryos with RFP signal during 
icd-1/icd-2(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) were: 
66.67%, 53.33%, and 31.82%, respectively. The percentage of untreated four-fold 
embryos with RFP signal was 80.00% (Table 2).  
 
Table 2. Percentage of four-fold stage embryos with RFP signal in comparison to total 
number of embryos viewed during indicated RNAi treatment. 
Percentage of four-fold embryos with RFP signal 
  icd-1(RNAi) icd-2(RNAi) icd-1/icd-2(RNAi) Control 
12 hours 60.00 44.44 66.67 80.00 
24 hours 38.89 66.67 53.33 
 36 hours 52.94 23.68 31.82 
  
In general, as time of exposure to RNAi treatment increased, the percent of 
embryos with signal decreased. When three-fold embryos expressing RFP were 
compared, different localization patterns were present. Most strikingly, icd-1(RNAi) 
three-fold embryos displayed larger, punctate Gut::RFP aggregations relative to the other 
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treatment groups and the control treatment (Figure 3). Four-fold stage embryos 
expressing RFP during all RNAi treatments displayed large, punctate signals similar to 
icd-1(RNAi) three-fold embryos, but in all cases, this pattern was more widespread 
throughout the gut (Figure 4). To characterize and quantify the similarities and 
differences of Gut::RFP signal among the different treatment groups, all further data 
analyses were done on three-fold and four-fold embryos displaying fluorescent signal.  
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Figure 3. RFP signal in three-fold stage embryos after 24 hours of exposure to 
specific RNAi treatments. C. elegans with a Gut::RFP expression vector were fed (A) 
icd-1(RNAi)-specific bacteria, (B) icd-2(RNAi)-specific bacteria, (C) icd-1(RNAi)-
specific bacteria and icd-2(RNAi)-specific bacteria, or (D) OP50-1 (E. coli) bacteria 
expressing no double stranded RNA for 24 hours, and their progeny embryos were 
randomly assessed for expression of RFP using confocal microscopy. DIC and 
fluorescent images were overlaid with ImageJ software. Arrow indicates large, punctate 
Gut::RFP signal.   
 
	  28	  
  
Figure 4. RFP signal in four-fold stage embryos after 24 hours of exposure to 
specific RNAi treatments. C. elegans with a Gut::RFP expression vector were fed (A) 
icd-1(RNAi)-specific bacteria, (B) icd-2(RNAi)-specific bacteria, (C) icd-1(RNAi)-
specific bacteria and icd-2(RNAi)-specific bacteria, or (D) OP50-1 (E. coli) bacteria 
expressing no double stranded RNA for 24 hours, and their progeny embryos were 
randomly assessed for expression of RFP using confocal microscopy. DIC and 
fluorescent images were overlaid with ImageJ software. Arrow indicates large, punctate 
Gut::RFP signal.  
 
A B 
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Depletion of the ICD-1 and/or ICD-2 subunit significantly affects levels of RFP 
expression in embryos   
The qualitative differences in RFP expression patterns observed between RNAi 
treatment groups led us to ask if depletion of different NAC subunits resulted in 
significant quantitative differences in RFP expression. One measure of these putative 
differences in expression is to quantify the amount of RFP fluorescence expressed in 
individual embryos, otherwise known as mean pixels (RFP signal) per area unit (the 
embryo).  
To determine the effect of NAC individual subunit depletion on the amount of 
RFP expressed per embryo, ICD-1, ICD-2, and ICD-1/ICD-2 depleted embryos were 
examined and the mean pixels per area unit (arbitrary units) of each embryo was 
calculated from the image analysis data output. The mean pixels per area unit values for 
individual icd-1(RNAi) treated three-fold embryos by time points (12 hours, 24 hours, 
and 36 hours) were: 78.26 ± 22.55, 58.11 ± 23.17, and 58.10 ± 21.04, respectively, while 
for icd-2(RNAi) treated embryos, mean pixels per area unit for the same time points 
were: 61.45 ± 19.57, 44.41 ± 34.15, and 51.38 ± 42.73, respectively. The mean pixels per 
area unit for individual icd-1/icd-2(RNAi) treated three-fold embryos by time points (12 
hours, 24 hours, and 36 hours) were: 36.41 ± 22.04, 46.29 ± 14.41, and 49.89 ± 14.55, 
respectively. Untreated embryos displayed a mean pixels per area unit value of 13.18 ± 
7.91 (Table 3).  
 
 
 
	  30	  
Table 3. Average level of RFP expression in three-fold embryos after exposure to 
specific RNAi treatments over time. Mean pixels per area unit (arbitrary units) for 
individual three-fold stage embryos exposed to icd-1(RNAi), icd-2(RNAi), or icd-1/icd-
2(RNAi) were determined every 12 hours for 36 hours as a measure of RFP expression, 
and expressed as an average. 
Average level of RFP expression in individual embryos 
  icd-1 RNAi icd-2 RNAi icd-1/icd-2 RNAi Control 
12 hours 78.26 ± 22.55 61.45 ± 19.57 36.41 ± 22.04 13.18 ± 7.91 
24 hours 58.11 ± 23.17 44.41 ± 34.15 46.29 ± 14.41   
36 hours 58.10 ± 21.04 51.38 ± 42.73 49.89 ± 14.55   
 
The results of these experiments were analyzed with a two-way ANOVA to 
determine the statistical significance between the treatments for each time point (Figure 
5A-C). When the 12 hour time point of the three-fold stage embryos was compared, icd-
1(RNAi), icd-2(RNAi), icd-1/icd-2(RNAi) and control treatments had statistically 
significant differences relative to each other with a p-value of <0.0001. A Tukey post-hoc 
test is conducted if there is a statistically significant difference present from the ANOVA. 
An ANOVA test examines if there are any differences present between the treatments 
where as a Tukey post-hoc test examines the differences between each treatment in 
comparison to the other individual treatments. A Tukey post-hoc test indicated that the 
differences lie between the RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and 
control treatments with an alpha value of 0.05. Additionally, the post-hoc test indicated 
statistically significant differences between all RNAi (icd-1 to icd-2, icd-1 to icd-1/icd-2, 
and icd-2 to icd-1/icd-2) treatments with an alpha value of 0.05. When the 24 hour time 
point of the three-fold stage embryos was compared, RNAi (icd-1(RNAi), icd-2(RNAi), 
icd-1/icd-2(RNAi)) and control treatments had statistically significant differences with a 
p-value of <0.0001. A Tukey post-hoc test indicated that the differences lie between the 
RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments with an 
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alpha value of 0.05. When the 36 hour time point of the three-fold stage embryos was 
compared, RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control 
treatments had statistically significant differences with a p-value of <0.0001. A Tukey 
post-hoc test indicated that the differences lie between the RNAi (icd-1(RNAi), icd-
2(RNAi), icd-1/icd-2(RNAi)) and control treatments with an alpha value of 0.05.  
The mean pixels per area unit data were also analyzed with a two-way ANOVA to 
determine the statistical significance between the time points within each treatment 
(Figure 5D-F). When the three-fold stage embryos exposed to icd-1(RNAi) treatment 
were compared, the 12 hour, 24 hour, and 36 hour had statistically significant differences 
with a p-value of 0.0030. A Tukey post-hoc test indicated that the differences lie between 
the 12 hour to the 24 hour and the 12 hour to the 36 hour with an alpha value of 0.05. 
When the three-fold stage embryos exposed to icd-2(RNAi) treatment were compared, 
the 12 hour, 24 hour, and 36 hour did not have a statistically significant difference with a 
p-value of 0.3452. When the three-fold stage embryos exposed to icd-1/icd-2(RNAi) 
treatment were compared, the 12 hour, 24 hour, and 36 hour did not have a statistically 
significant difference with a p-value of 0.2151. 
At all time points (12, 24, and 36 hours) of exposure to RNAi treatments, the 
three-fold stage embryos exposed to the icd-1(RNAi) treatment had the largest value of 
mean pixels per area unit while the control treatment had the smallest value (Figure 5A-
C). Under icd-1(RNAi) and icd-2(RNAi) treatments, the three-fold stage embryos within 
the 12 hour time point had the largest value of mean pixels per area unit whereas the 24 
hour time point had the smallest value (Figure 5D-E). Alternatively, under icd-1/icd-
2(RNAi) treatment, three-fold stage embryos within the 36 hour time point had the 
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largest value of mean pixels per area unit and the 12 hour time point had the smallest 
value (Figure 5F).  
 
Figure 5. Average RFP expression levels for three-fold stage embryos exposed to 
specific RNAi treatments for increasing amounts of time. C. elegans with a Gut::RFP 
expression vector were exposed to the indicated RNAi treatment or OP50-1 (E. coli) 
bacteria expressing no double stranded RNA and their progeny embryos were randomly 
assessed for expression of RFP using confocal microscopy. Images were processed to 
determine the mean pixels per area unit with ImageJ software. (A) 12 hour time point of 
RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments. (B) 24 
hour time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control 
treatments. (C) 36 hour time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-
2(RNAi)) and control treatments. (D) 12, 24, and 36 hour time points for icd-1(RNAi) 
treatment. (E) 12, 24, and 36 hour time points for icd-2(RNAi) treatment. (F) 12, 24, and 
36 hour time points for icd-1/icd-2(RNAi) treatment. Black asterisks indicate statistically 
significant difference between RNAi treatment and control treatment. Red asterisks 
indicate statistically significant difference between RNAi treatments. Blue asterisks 
indicate statistically significant difference between time points.  
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The mean pixels per area unit values for individual four-fold embryos exposed to   
icd-1(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) four-fold were: 
76.51 ± 46.48, 43.84 ± 18.01, and 71.07 ± 42.08, respectively, while for those exposed to 
icd-2(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) four-fold were: 
63.92 ± 22.50, 37.31 ± 22.41, and 71.88 ± 48.77, respectively. The mean pixels per area 
unit values for individual four-fold embryos exposed to icd-1/icd-2(RNAi) treatment by 
time points (12 hours, 24 hours, and 36 hours) four-fold were: 39.25 ± 31.10, 42.62 ± 
14.78, and 45.23 ± 20.38, respectively. Untreated embryos displayed a mean pixels per 
area unit value of four-fold 15.58 ± 6.07 (Table 4).  
 
Table 4. Average level of RFP expression in four-fold embryos after exposure to specific 
RNAi treatments over time. Mean pixels per area unit (arbitrary units) for individual 
four-fold stage embryos exposed to icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi) 
were determined every 12 hours for 36 hours as a measure of RFP expression, and 
expressed as an average. 
Average level of RFP expression in individual embryos Four-fold 
  icd-1(RNAi) icd-2(RNAi) icd-1/icd-2(RNAi) Control 
12 hours 76.51 ± 46.48 63.92 ± 22.50 39.25 ± 31.10 15.58 ± 6.07 
24 hours 43.84 ± 18.01 37.31 ± 22.41 42.62 ± 14.78   
36 hours 71.07 ± 42.08 71.88 ± 48.77 45.23 ± 20.38   
 
The mean pixels per area unit data were analyzed with a two-way ANOVA to 
determine the statistical significance between the treatments for each time point (Figure 
6A-C). When the 12 hour time point of the four-fold stage embryos was compared, RNAi 
(icd-1(RNAi), icd-2(RNAi), icd-1/icd-2(RNAi)) and control treatments had statistically 
significant differences with a p-value of <0.0001. A Tukey post-hoc test indicated that 
the differences lie between the icd-1(RNAi) and icd-2(RNAi) treatments and the control 
with an alpha value of 0.05. Additionally, the post-hoc test indicated statistically 
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significant differences between icd-1 RNAi and icd-1/icd-2(RNAi) treatments with an 
alpha value of 0.05. When the 24 hour time point of the four-fold stage embryos was 
compared, RNAi (icd-1(RNAi), icd-2(RNAi),  icd-1/icd-2(RNAi)) and control treatments 
had statistically significant differences with a p-value of <0.0001. A Tukey post-hoc test 
indicated that the differences lie between the RNAi (icd-1(RNAi), icd-2(RNAi), or icd-
1/icd-2(RNAi)) and the control treatment with an alpha value of 0.05. When the 36 hour 
time point of the four-fold stage embryos was compared, RNAi (icd-1(RNAi), icd-
2(RNAi), or icd-1/icd-2(RNAi)) and control treatments had statistically significant 
differences with a p-value of <0.0001. A Tukey post-hoc test indicated that the 
differences lie between the icd-1(RNAi) and icd-2(RNAi) treatments and the control with 
an alpha value of 0.05.  
The mean pixels per area unit data were also analyzed with a two-way ANOVA to 
determine the statistical significance between the time points within each treatment 
(Figure 6D-F). When the four-fold stage embryos exposed to icd-1(RNAi) treatment were 
compared, the 12 hour, 24 hour, and 36 hour did not have a statistically significant 
difference with a p-value of 0.0696. When the four-fold stage embryos exposed to icd-
2(RNAi) treatment were compared, the 12 hour, 24 hour, and 36 hour had statistically 
significant differences with a p-value of 0.0205. A Tukey post-hoc test indicated that the 
differences lie between the 24 hour and 36 hour time points with an alpha value of 0.05. 
When the four-fold stage embryos exposed to icd-1/icd-2(RNAi) treatment were 
compared, the 12 hour, 24 hour, and 36 hour did not have a statistically significant 
difference with a p-value of 0.8831. 
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At the 12 and 24 hour time points of exposure to RNAi treatments, the four-fold 
stage embryos exposed to icd-1(RNAi) treatment had the largest value of mean pixels per 
area unit while the control treatment had the smallest value (Figure 6A-B). At the 36 hour 
time point of exposure to RNAi treatments, four-fold stage embryos exposed to the icd-
2(RNAi) treatment had the largest value of mean pixels per area unit and the control 
treatment had the smallest value (Figure 6C). Under icd-1(RNAi) treatment, the four-fold 
stage embryos within the 24 hour time point had the largest value (Figure 6D). 
Additionally, under the icd-2(RNAi) treatment, four-fold stage embryos within the 12 
hour time point had the largest value (Figure 6E). Finally, under icd-1/icd-2(RNAi) 
treatment, four-fold stage embryos within the 36 hour time point had the largest value of 
mean pixels per area unit and the 12 hour time point had the smallest (Figure 6F).  
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Figure 6. Average RFP expression levels for four-fold stage embryos exposed to 
specific RNAi treatments for increasing amounts of time. C. elegans with a Gut::RFP 
expression vector were exposed to the indicated RNAi treatment or OP50-1 (E. coli) 
bacteria expressing no double stranded RNA and their progeny embryos were randomly 
assessed for expression of RFP using confocal microscopy. Images were processed to 
determine the mean pixels per area unit with ImageJ software. (A) 12 hour time point of 
RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments. (B) 24 
hour time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control 
treatments. (C) 36 hour time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-
2(RNAi)) and control treatments. (D) 12, 24, and 36 hour time points for icd-1(RNAi) 
treatment. (E) 12, 24, and 36 hour time points for icd-2(RNAi) treatment. (F) 12, 24, and 
36 hour time points for icd-1/icd-2(RNAi) treatment. Black asterisks indicate statistically 
significant difference between RNAi treatment and control treatment. Red asterisks 
indicate statistically significant difference between RNAi treatments. Blue asterisks 
indicate statistically significant difference between time points.  
 
The mean pixels per area unit data were also analyzed with a Student’s T-test to 
determine the statistical significance between the stages for each time point within each 
treatment (Table 5). The comparison of the 24 hour time point within the icd-1(RNAi) 
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treatment between the three-fold and the four-fold stage embryos had a statistically 
significant difference with a p-value of 0.0446. The remainder of the comparisons of each 
individual time point for each specific RNAi treatment between the two stages of 
embryos did not show any statistically significant differences as indicated by p-values 
greater than 0.05 (Table 5). 
 
Table 5. Calculated p-values from Student’s T-tests for the comparison of the mean 
pixels per unit area of three-fold and four-fold stage embryos relative to each other.  
  icd-1(RNAi) icd-2(RNAi) icd-1/icd-2(RNAi) 
  
12 
hours 
24 
hours 
36 
hours  
12 
hours 
24 
hours 
36 
hours  
12 
hours 
24 
hours 
36 
hours  
p-value 0.887 0.044 0.282 0.581 0.458 0.284 0.823 0.623 0.577 
 
Overall from the Student’s T test, the three-fold and four-fold stages were not 
significantly different for expression of RFP at any time point for any of the RNAi 
treatments. However, the icd-1(RNAi) at the 24 hour time point was statistically 
significant between three-fold and four-fold stage embryos. Conversely, both three-fold 
and four-fold stage embryos showed significant differences in RFP expression at all time 
points for all RNAi treatments (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) when 
compared to controls.  
 
Depletion of the ICD-1 and/or ICD-2 subunit significantly affects intensity of RFP signal 
in embryos  
The qualitative differences in the intensity of RFP signal, particularly in the large 
punctate structures observed between RNAi treatment groups (Figures 3 and 4) led us to 
ask if depletion of different NAC subunits resulted in significant quantitative differences 
in intensity of RFP signal. Such differences may correlate strength of stress response 
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and/or rate of progression through differentiation with specific RNAi treatments. One 
measure of these putative differences in signal intensity is to quantify the strength of RFP 
fluorescence expressed in each individual embryo in a given treatment group, otherwise 
known as mean pixel intensity.  
To determine the effect of NAC individual subunit depletion on the intensity of 
RFP signal in individual embryos, ICD-1, ICD-2, and ICD-1/ICD- 2 depleted embryos 
were examined and the mean pixel intensity (arbitrary units) was calculated from the 
image analysis output. The mean intensity values for three-fold embryos exposed to icd-
1(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) were: 627.97 ± 
224.31, 588.91 ± 119.09, and 554.69 ± 65.96, respectively, while those exposed to icd-
2(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) were: 443.73 ± 
44.17, 418.70 ± 42.69, and 425.31 ± 23.63, respectively. The mean intensity values for 
three-fold embryos exposed to icd-1/icd-2(RNAi) treatment by time points (12 hours, 24 
hours, and 36 hours) were: 631.92 ± 48.09, 582.04 ± 27.63, and 583.62 ± 64.27, 
respectively. The mean intensity value for the control treatment was 1511.71 ± 330.52 
(Table 6).  
 
Table 6. Average intensity of RFP signal in three-fold embryos after exposure to specific 
RNAi treatments over time. Mean pixel intensity (arbitrary units) for three-fold stage 
embryos exposed to icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi) were determined 
every 12 hours for 36 hours as a measure of RFP signal intensity and expressed as an 
average. 
Three Fold Mean Intensity 
  icd-1(RNAi) icd-2(RNAi) icd-1/icd-2(RNAi) Control 
12 hours 627.97 ± 224.31 443.73 ± 44.17 631.92 ± 48.09 1511.71 ± 330 
24 hours 588.91 ± 119.09 418.70 ± 42.69 582.04 ± 27.63   
36 hours 554.69 ± 65.96 425.31 ± 23.63 583.62 ± 64.27   
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The mean pixel intensity data were analyzed with a two-way ANOVA to 
determine the statistical significance between the treatments for each time point (Figure 
7A-C). When the 12 hour time point of the three-fold stage embryos was compared, 
RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments had 
statistically significant differences with a p-value of <0.0001. A Tukey post-hoc test 
indicated that the differences lie between the RNAi (icd-1(RNAi), icd-2(RNAi), or icd-
1/icd-2(RNAi)) treatments and the control treatment with an alpha value of 0.05. When 
the 24 hour time point of the three-fold stage embryos was compared, RNAi (icd-
1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments had statistically 
significant differences with a p-value of <0.0001. A Tukey post-hoc test indicated that 
the differences lie between the RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) 
treatments and the control treatment with an alpha value of 0.05. When the 36 hour time 
point of the three-fold stage embryos was compared RNAi (icd-1(RNAi), icd-2(RNAi), 
or icd-1/icd-2(RNAi)) and control treatments had statistically significant differences with 
a p-value of <0.0001. A Tukey post-hoc test indicated that the differences lie between the 
RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) treatments and the control 
treatment with an alpha value of 0.05.  
The mean pixel intensity data were also analyzed with a two-way ANOVA to 
determine the statistical significance between the time points within each treatment. 
When the three-fold embryos exposed to icd-1(RNAi) treatment were compared, the 12 
hour, 24 hour, and 36 hour did not have a statistically significant difference with a p-
value of 0.2935. When the three-fold stage embryos exposed to icd-2(RNAi) treatment 
were compared, the 12 hour, 24 hour, and 36 hour did not have a statistically significant 
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difference with a p-value of 0.1613. When the three-fold stage embryos exposed to icd-
1/icd-2(RNAi) treatment were compared, the 12 hour, 24 hour, and 36 hour did not have 
a statistically significant difference with a p-value of 0.0657. 
At the 12 hour, 24 hour, and 36 hour time point of exposure to RNAi treatments, 
the three-fold stage embryos exposed to icd-2(RNAi) treatment had the smallest value of 
mean pixel intensity while the control treatment had the largest value (Figure 7A-C). 
Under RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) treatment, the three-fold 
stage embryos within the 12 hour time point had the largest value (Figure 7D-F).  
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Figure 7. Average RFP intensity levels for three-fold stage embryos exposed to 
specific RNAi treatments for increasing amounts of time C. elegans with a Gut::RFP 
expression vector were exposed to the indicated RNAi treatment or OP50-1 (E. coli) 
bacteria expressing no double stranded RNA and their progeny embryos were randomly 
assessed for level  of RFP intensity using confocal microscopy. Images were processed to 
determine the mean pixel intensity with ImageJ software. (A) 12 hour time point of RNAi 
(icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments. (B) 24 hour 
time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control 
treatments. (C) 36 hour time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-
2(RNAi)) and control treatments.  (D) 12, 24, and 36 hour time points for icd-1(RNAi) 
treatment. (E) 12, 24, and 36 hour time points for icd-2(RNAi) treatment. (F) 12, 24, and 
36 hour time points for icd-1/icd-2(RNAi) treatment. Black asterisks indicate statistically 
significant difference between RNAi treatment and control treatment. Red asterisks 
indicate statistically significant difference between RNAi treatments. Blue asterisks 
indicate statistically significant difference between time points.  
 
The mean intensity values (arbitrary units) for four-fold stage embryos exposed to  
icd-1(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) were: 589.44 ± 
244.27, 606.03 ± 76.55, and 510.19 ± 75.58, respectively while those exposed to icd-
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2(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) were: 436.63 ± 
53.70, 409.83 ± 45.58, and 420.30 ± 27.45, respectively. The mean intensity values for 
four-fold embryos exposed to icd-1/icd-2(RNAi) treatment by time points (12 hours, 24 
hours, and 36 hours)  were: 594.01 ± 54.52, 603.34 ± 53.50, and 619.86 ± 66.25, 
respectively. The mean intensity value for the control treatment was 1481.96 ± 295.83 
(Table 7).  
 
Table 7. Average intensity of RFP signal in four-fold embryos after exposure to specific 
RNAi treatments over time. Mean pixel intensity (arbitrary units) for four-fold stage 
embryos exposed to icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi) were determined 
every 12 hours for 36 hours as a measure of RFP signal intensity and expressed as an 
average. 
 
Four-fold Mean Intensity 
  icd-1(RNAi) icd-2(RNAi) icd-1/icd-2(RNAi) Control 
12 hours 589.44 ± 244.27 436.63 ± 53.70 594.01 ± 54.52 1481.96 ± 295.83 
24 hours 606.03 ± 76.55 409.83 ± 45.58 603.34 ± 53.50   
36 hours 510.19 ± 75.58 420.30 ± 27.45 619.86 ± 66.25   
 
The mean pixel intensity data were analyzed with a two-way ANOVA to 
determine the statistical significance between the treatments for each time point (Figure 
8A-C). When the 12 hour time point of the four-fold stage embryos was compared, RNAi 
(icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments had 
statistically significant differences with a p-value of <0.0001. A Tukey post-hoc test 
indicated that the differences lie between the RNAi (icd-1(RNAi), icd-2(RNAi), or icd-
1/icd-2(RNAi)) treatments and the control treatment with an alpha value of 0.05. When 
the 24 hour time point of the four-fold stage embryos was compared, RNAi (icd-
1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments had statistically 
significant differences with a p-value of <0.0001. A Tukey post-hoc test indicated that 
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the differences lie between the RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) 
treatments and the control treatment with an alpha value of 0.05. Additionally, the post-
hoc test indicated statistically significant differences between icd-1(RNAi) and icd-
2(RNAi) treatments with an alpha value of 0.05. When the 36 hour time point of the four-
fold stage embryos was compared, RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-
2(RNAi)) and control treatments had statistically significant differences with a p-value of 
<0.0001. A Tukey post-hoc test indicated that the differences lie between the RNAi (icd-
1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) treatments and the control treatment with 
an alpha value of 0.05. 
The mean pixel intensity unit data were also analyzed with a two-way ANOVA to 
determine the statistical significance between the time points within each treatment 
(Figure 8D-F). When the four-fold stage embryos exposed to icd-1(RNAi) treatment were 
compared, the 12 hour, 24 hour, and 36 hour did not have a statistically significant 
difference with a p-value of 0.2916. When the four-fold stage embryos exposed to icd-
2(RNAi) treatment were compared, 12 hour, 24 hour, and 36 hour did not have a 
statistically significant difference with a p-value of 0.3640. When the four-fold stage 
embryos exposed to icd-1/icd-2(RNAi) treatment were compared, 12 hour, 24 hour, and 
36 hour did not have a statistically significant difference with a p-value of 0.6906. 
At the 12 hour, 24 hour, and 36 hour time point of exposure to RNAi treatments, 
the four-fold stage embryos exposed to icd-2(RNAi) treatment had the smallest value of 
mean pixel intensity while the control treatment had the largest value (Figure 8A-C). 
Under icd-1(RNAi) treatment, the four-fold embryos within the 24 hour time point had 
the largest value (Figure 8D). Under the icd-2(RNAi) treatment, the four-fold embryos 
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within the 12 hour time point had the largest value (Figure 8E). Under the icd-1/icd-
2(RNAi) treatment, the four-fold embryos within the 36 hour time point had the largest 
value (Figure 8F).  
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Figure 8. Average RFP intensity levels for four-fold stage embryos exposed to 
specific RNAi treatments for increasing amounts of time.  C. elegans with a Gut::RFP 
expression vector were exposed to the indicated RNAi treatment or  OP50-1 (E. coli) 
bacteria expressing no double stranded RNA and their progeny embryos were randomly 
assessed for level of RFP intensity using  confocal microscopy. Images were processed to 
determine the mean pixel intensity with ImageJ software. (A) 12 hour time point of RNAi 
(icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments. (B) 24 hour 
time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control 
treatments. (C) 36 hour time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-
2(RNAi)) and control treatments. (D) 12, 24, and 36 hour time points for icd-1(RNAi) 
treatment. (E) 12, 24, and 36 hour time points for icd-2(RNAi) treatment. (F) 12, 24, and 
36 hour time points for icd-1/icd-2(RNAi) treatment. Black asterisks indicate statistically 
significant difference between RNAi treatment and control treatment. Red asterisks 
indicate statistically significant difference between RNAi treatments. Blue asterisks 
indicate statistically significant difference between time points.  
 
The mean pixel intensity data were also analyzed with a Student’s T-test to 
determine the statistical significance between the stages for each time point within each 
treatment (Table 8).  The comparisons of each individual time point for each specific 
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RNAi treatment between the two stages of embryos did not show any statistically 
significant differences as indicated by p-values greater than 0.05 (Table 8).	   
 
Table 8. Calculated p-values from Student’s T-tests for the comparison of the mean pixel 
intensity of three-fold and four-fold stage embryos relative to each other. 
  icd-1 RNAi icd-2 RNAi icd-1/icd-2 RNAi 
  
12 
hours 
24 
hours 
36 
hours  
12 
hours 
24 
hours 
36 
hours  
12 
hours 
24 
hours 
36 
hours  
p-value 0.6752 0.6217 0.1234 0.7344 0.5393 0.6353 0.1367 0.3342 0.2660 
 
Colocalization of HSP-4::GFP/Gut::RFP under control treatment 
Previous studies on the management of misfolded protein stress in C. elegans identified 
cell-types specific differences in stress response outcomes induced by depletion of the 
NAC. Neurons appeared more sensitive to apoptosis in response to misfolded protein 
stress relative to other cell types, e.g. gut cells, due possibly to the sub-optimal expression 
of the UPR-specific chaperone HSP-4 16,18. These studies speculate as to, but do not 
confirm, the nature of the cell types expressing and not expressing detectible levels of 
HSP-4 in response to misfolded protein stress. To determine if gut cells are resistant to 
NAC-depletion induced apoptosis due to the upregulation of HSP-4, we planned to 
determine the putative co-localization of the HSP-4::green fluorescent protein (GFP) 
reporter protein with Gut::RFP. Before these experiments can be performed though, we 
established the localization patterns of both fluorescent proteins in untreated animals. 
To establish a baseline expression pattern that will allow us to characterize the 
effect of NAC individual subunit depletion on the colocalization of gut cells and heat 
shock protein 4 (HSP-4), untreated embryos expressing both reporter constructs were 
allowed to develop into adults (48 hours post first cleavage) and subsequently examined 
for Gut::RFP and HSP-4::GFP. Adult worms were observed with confocal microscopy to 
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determine a baseline expression of signal for HSP-4::GFP and Gut::RFP signals. Once 
images were captured, fluorescent signal was quantified by calculating mean colocalized 
pixels per area unit (arbitrary units), which was 0.6337± 0.0734. The adults were 
analyzed with a Colocalization program within ImageJ (National Institute of Health) to 
give an output image with only the colocalized areas to determine the amount of 
overlapping signal from the HSP-4::GFP signal and the Gut::RFP signal. Additionally, all 
fluorescent channels and DIC images were overlaid to show colocalization patterns. 
Colocalization, as indicated by the yellow color, was primarily localized to the anterior 
and posterior regions of the gut (Figure 9).  
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Figure 9. Adult HSP-4::GFP/Gut::RFP worm under control treatment. C. elegans 
with the hsp-4::GFP and Gut::RFP expression vectors were fed OP50-1 (E. coli) bacteria 
expressing no double stranded RNA and their progeny embryos were allowed to develop 
into adults and were randomly assessed for RFP and GFP expression with confocal 
microscopy. DIC and fluorescent images were overlaid with ImageJ software. (A) GFP 
signal overlaid with DIC image, (B) RFP signal overlaid with DIC image, (C) GFP and 
RFP signal overlaid with DIC image. Co-localized pixels are visualized as yellow.  
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DISCUSSION 
Historically, investigations of the function of the nascent polypeptide-associated 
complex (NAC) in C. elegans have been conducted in the context of beta subunit 
depletions. These studies lack the depletion of the entire complex and, instead leave the 
alpha subunit in relative excess. Previous research has indicated that there are individual 
functions that each subunit can perform when not complexed with its binding partner. 
Alpha NAC has been implicated as a transcription factor regulating cell differentiation22–
25. Conversely, beta NAC has not been as well characterized as alpha NAC as an 
individual subunit, but was originally identified as a transcription factor, and may play a 
role as a cytosolic chaperone when not bound by alpha NAC 15. From previous research, 
one can conclude that these subunits likely function independently and therefore, 
phenotypes associated with the depletion of one subunit may be related to the loss of the 
NAC, the activity of the other subunit, or both. These studies investigated the depletion 
of  individual subunits and the depletion of both subunits simultaneously to determine 
any differential effects as related to gut cell development and viability.  
The level of Gut::RFP signal is indicative of the amount of this peroxisomal  
fusion protein present in the organism. A relatively low level of this protein could result 
from two outcomes: fewer peroxisomes present in the gut cells or fewer gut cells present 
in the organism. The first scenario could result from no significant change in the number 
of differentiated gut cells but rather, is a measure of the number of peroxisomes. The 
second scenario could result from a significant change in the number of differentiated gut 
cells indicated by the number of peroxisomes present within each cell. For the remainder 
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of this interpretation, we are hypothesizing that changes in peroxisome RFP signal are 
due to an effect on gut cell differentiation, and not on peroxisome biogenesis.  
From the data presented, the percentage of Gut::RFP signal present within the 
three-fold and four-fold staged embryos showed a significant difference when comparing 
all RNAi treatments with the controls. Specifically, parental worms exposed to any NAC 
subunit depletion produced fewer embryos with Gut::RFP signal relative to untreated 
controls (Table 1 and 2). As such, depletion of alpha NAC, beta NAC or both affected the 
likelihood of progeny embryos displaying RFP signal. One interpretation of these results 
is a loss of gut cells in embryos unable to cope with the misfolded protein stress present, 
leading to debilitation and perhaps even death. Conversely, those embryos that do express 
Gut::RFP in the face of the misfolded protein stress may have generated a robust stress 
response that maintains the viability of the gut cell. This response may also display 
different phenotypic profiles depending specifically on the corresponding depletion. To 
characterize such putative differences, we proceeded to quantify the Gut::RFP signals 
generated in the RNAi treatment populations. When interpreting data, one must consider 
that this is a narrowed population view in terms of those embryos that survived the RNAi 
(icd-1(RNAi) icd-2(RNAi), or icd-1/icd-2(RNAi)) treatments and also expressed 
detectible Gut::RFP signal.  
Mean pixels per area unit quantifies the number of pixels throughout an individual 
embryo. This assessment can be used as a direct measure of  level of peroxisomal fusion 
protein expression within the embryo and, therefore, the number of peroxisomes within 
gut cells. Overall, the three-fold and four-fold stages of the RNAi (icd-1(RNAi) icd-
2(RNAi), or icd-1/icd-2(RNAi)) treatments showed a significant increase in mean pixels 
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per area unit from the control treatment. Under the previous assumption that Gut::RFP 
signal is indicative of the number of gut cells, this increase in mean pixels per area unit 
could indicate a larger number of differentiated gut cells. Premature or atypical 
differentiation is a documented response to cell stress in other organisms, which could 
explain this increase in gut cells during NAC depletion in C. elegans. Notably, within the 
12 hour time point, all RNAi treatments were significantly different from each other in 
terms of average RFP signal generated. These results support the hypothesis that 
phenotypes associated with depletion of one subunit may be the result of both the loss of 
the NAC and the activity of the remaining, unbound subunit. This difference suggests 
that when in excess of its binding partner, the alpha or beta subunit has different 
functions within the cell than they do when in complex with each other. When comparing 
the average RFP signal generated in each population, trends emerge: icd-1(RNAi) had the 
largest average RFP signal per embryos followed by icd-2(RNAi) and the icd-1/icd-
2(RNAi). The icd-1(RNAi) has excess alpha NAC present relative to beta NAC and also 
has the highest value of mean pixels per area unit that could indicate more differentiated 
gut cells. These results are consistent with alpha NAC’s known roles in other systems as 
a transcription factor associated with cell differentiation22,24,25. In those cases, alpha NAC 
facilitates the differentiation of cells that generate high levels of protein at some point 
during their progression, e.g. the making of bone matrix as an osteoblast converts to an 
osteocyte22,23. These results are also consistent with stress-induced differentiation of 
mammalian intestinal and esophageal cells undergoing misfolded protein stress26.  
Mean pixel intensity quantifies the number of Gut::RFP fusion proteins  
occupying a defined space within the cell. This measurement could be indicative of two 
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different phenomena: the inappropriate differentiation of other cell types under stress to 
become gut cells, or the premature differentiation of stressed gut cells relative to other 
gut cells within the same organism. In the former situation weak Gut::RFP pixel intensity 
may be due to inappropriate differentiation of cells not destined to become gut cells. This 
situation could be interpreted in relation to the functionality of the peroxisomes; these 
cells were never intended to be gut cells, and therefore may have a decreased capacity to 
make peroxisomes relative to normal gut cells, resulting in decreased mean pixel 
intensity. The second interpretation of differential Gut::RFP pixel intensity would 
potentially indicate the premature differentiation of a gut cell. If misfolded protein stress 
has driven a gut cell to differentiate prematurely, the accumulation of peroxisomes  
would be greater in those cells relative to neighboring gut cells that may have 
differentiated in the appropriate time frame. Therefore, a higher mean pixel intensity 
could be the result of misfolded protein stress driving a gut cell to differentiate 
prematurely.  
Future studies to distinguish between inappropriate differentiation and the specific 
timing of differentiation could observe individual cells destined to develop into gut cells. 
These cell lineage observations would follow each individual cell throughout their 
development during depletion of the individual subunits of the NAC to monitor the 
specific time and place of  differentiation as determined by the appearance of the reporter 
signal. Individual gut cell boundaries could be marked to quantify the number of 
individual peroxisomes within the cell. This assessment would distinguish between an 
increase in number of peroxisomes in gut cells versus an increase in gut cells and 
therefore the number of peroxisomes. The three-fold and four-fold stages of the RNAi 
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(icd-1(RNAi) icd-2(RNAi), and icd-1/icd-2(RNAi)) treatments showed a significant 
decrease in mean pixel intensity from the control treatment. This suggests that there were 
gut cells that differentiated inappropriately due to the cell stress response and these gut 
cells have lower functionality within their peroxisomes than the gut cells that were 
destined to differentiate under normal cellular conditions. The lower functionality of the 
peroxisomes is indicated by the significant decrease in the reporter fusion protein that is 
produced within peroxisomes. Overall, icd-1(RNAi) had a larger mean pixel intensity 
value than icd-2(RNAi) and was statistically significant at the 24 hour time point of the 
four-fold stage embryos. As previously stated, RNAi assays have a spectrum of effects 
within the treatment, the range of data values for the majority of the reported time points 
for both stages of embryos does not indicate any significance. With the continuation of 
trials, more distinct and statistically significant trends may emerge to support the 
preliminary evidence that we have defined at the 24 hour time point for four-fold stage 
embryos. 
From the conducted Student’s T-test between the three-fold stage and four-fold 
stage embryos values for mean pixels per area unit and the mean pixel intensity, overall, 
no significant difference was found. The only statistically significant difference between 
the three-fold and four-fold stage embryos was during icd-1(RNAi) treatment at the 24 
hour time point and as such, no discernable trend in differences can be made between the 
two stages of embryos. In general, all RNAi treatments in both stages of embryos 
rendered the same trends: more gut cells differentiated inappropriately as indicated by the 
higher amount of mean pixels per area unit compared to the control treatment. However, 
this increase in differentiated gut cells resulting from all RNAi treatments did not 
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generate cells with the same functionality or the same time of differentiation as the 
control treatment as indicated by mean pixel intensity. These results may indicate that 
misfolded protein stress may be driving cells into early or atypical gut cell differentiation, 
but these cells are not adhering to a fully completed differentiation program, resulting in 
partially functional gut cells.  
Along with differentiation as a response to cell stress, the upregulation of 
chaperones can also occur, depending on cell type. Heat shock protein 4 (HSP-4) has 
been previously studied as a chaperone that is upregulated specifically during times of 
misfolded protein stress in the ER of C. elegans12. From these findings, there is evidence 
that the individual NAC subunits have functions related to the regulation of 
differentiation. We are now interested to determine how specific cell types respond to 
misfolded protein stress through upregulation of HSP-4. Increased expression of HSP-4 
indicates the engagement of UPR mechanisms focused on saving the cell and avoiding 
the initiation of apoptosis.  
The hsp-4::GFP/Gut::RFP reporter strain combines the ability to use HSP-4::GFP 
signal as a reporter for the management of cell stress with the ability to specifically 
identify gut cells within the animal. Using this co-expressing strain, we can now 
specifically monitor the expression of HSP-4, a cell saving UPR outcome, in gut cells in 
real time. These data establishes baseline co-localization data of HSP-4::GFP and 
Gut::RFP for comparison with localization data gathered from icd-1(RNAi), icd-
2(RNAi), or icd-1/icd-2(RNAi) treatments. Future studies will investigate the RNAi (icd-
1(RNAi) icd-2(RNAi), or icd-1/icd-2(RNAi)) treatments to determine any statistically 
significant deviation from this baseline control data. Additionally, future studies to 
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investigate other cell lineages, specifically neuronal and muscle cell lineages, would 
compare the cell-specific ability to manage stress in a similar way. Utilizing HSP-4::GFP 
as an indicator of stress management, the co-localization of cell lineage signals (gut, 
neuronal, and muscle) and the HSP-4::GFP would allow for the determination of cell 
specific stress responses. The working hypothesis is that neurons are unable to upregulate 
HSP-4 efficiently to cope with stress conditions resulting in a greater susceptibility to 
apoptosis. An accompanying hypothesis is that there are cell types such as gut and 
muscle cells, are able to upregulate HSP-4 effectively and resist apoptosis in the face of 
misfolded protein stress. This research has implications for neurodegenerative diseases in 
the context that neuronal cells are more susceptible to cell stress and will induce cell-
killing mechanisms. 
In conclusion, the protocol we’ve developed throughout this research has 
optimized the parameters used to determine the effects of NAC depletion on cell 
differentiation , specifically in the gut cells of C. elegans. With this methodology, 
differentiation of muscle and neuronal cells in NAC-depleted C. elegans can be observed 
and quantified using confocal microscopy to determine cell-type specific differentiation 
patterns under stress conditions. Furthermore, our work provides a framework for 
determining the upregulation of HSP-4 as a cell specific stress responses for gut, muscle, 
and neuronal cells in NAC-depleted C. elegans. These future studies will elucidate any 
differences in cell-type specific responses to misfolded protein stress, providing insights 
into why certain cell types are more susceptible to death during misfolded protein stress, 
and how this sensitivity could contribute to the development of disease. 
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